Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

被引：0
作者：
Dash, A. [1 ]
Pettus, J. A. [1 ]
Bochner, B. H. [1 ]
Dalbagni, G. [1 ]
Donat, S. M. [1 ]
Herr, H. W. [1 ]
Bajorin, D. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5077
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
    Kim, Hongsik
    Kim, Ryul
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Song, Wan
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Hong, Jung Yong
    Park, Se Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [32] Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High-Risk Muscle-Invasive Urothelial Carcinoma: A Real-World Study
    Wang, Yanjun
    Zhong, Kaihua
    Tan, Xingliang
    Zhou, Qianghua
    Jiang, Lijuan
    Yao, Kai
    Wu, Zhiming
    CANCER MEDICINE, 2025, 14 (04):
  • [33] Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
    Karaoglu, Aziz
    Nieh, Peter
    Canter, Daniel
    Master, Viraj A.
    Carthon, Bradley
    Harris, Wayne
    Shelton, Joseph
    Rossi, Peter John
    Jani, Ashesh B.
    Khan, Mohammad K.
    Osunkoya, Adeboya O.
    Ogan, Ken
    Pattaras, John
    Ritenour, Chad
    Kucuk, Omer
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder
    Alevizakos, Michail
    Bellmunt, Joaquim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (03) : 259 - 267
  • [35] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma reply
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2021, 22 (06) : E238 - E238
  • [36] Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma REPLY
    Bajorin, Dean F.
    Collette, Sandra
    Galsky, Matthew D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10) : 957 - 957
  • [37] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update
    Gupta, Shilpa
    Weight, Christopher J.
    Agarwal, Neeraj
    Gupta, Sumati
    Konety, Badrinath
    Gibb, Ewan
    Davicioni, Elai
    Thyagarajan, Bharat
    Sonpavde, Guru
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [38] Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma
    Hung, Sheng-Chun
    Wang, Shian-Shiang
    Yang, Chun-Kuang
    Li, Jian-Ri
    Cheng, Chen-Li
    Ou, Yen-Chuan
    Ho, Hao-Chung
    Chiu, Kun-Yuan
    Chen, Chuan-Shu
    ANTICANCER RESEARCH, 2017, 37 (04) : 1875 - 1883
  • [39] Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
    Achkar, Tala
    Parikh, Rahul A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 257 - +
  • [40] GEMCITABINE AND CISPLATIN NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA: PREDICTING RESPONSE AND ASSESSING OUTCOMES.
    Gandhi, Nilay
    Baras, Alexander
    Munari, Enrico
    Faraj, Sheila
    Reis, Leonardo
    Liu, Jen-Jane
    Kates, Max
    Hoque, Mohammad
    Berman, David
    Hahn, Noah
    Eisenberger, Mario
    Netto, George
    Schoenberg, Mark
    Bivalacqua, Trinity
    JOURNAL OF UROLOGY, 2015, 193 (04) : E923 - E924
12345